Mounjaro vs Ozempic UK: Key Differences | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro vs Ozempic UK - Price £124.99

Compare Mounjaro and Ozempic at the cheapest UK price from £124.99 plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro vs Ozempic UK: Clinical Differences Explained

Published on: June 03, 2026

Understanding mounjaro vs ozempic uk differences is essential when choosing the right weight loss treatment for your needs. Both medications are MHRA-licensed injectable therapies, but they work through distinct mechanisms and produce different clinical outcomes. At Cured Pharmacy, our UK-registered clinical team helps patients navigate these options with transparent pricing and expert guidance.

Mounjaro vs Ozempic UK: How They Work Differently

Mounjaro (tirzepatide) is the UK's first dual GIP/GLP-1 receptor agonist, activating two separate hormone pathways that regulate appetite and blood glucose control [1]. This dual mechanism distinguishes it from Ozempic (semaglutide), which activates only the GLP-1 receptor pathway. The additional GIP receptor activation in Mounjaro enhances insulin secretion and may contribute to greater weight reduction outcomes observed in clinical trials.

Ozempic contains semaglutide, a single GLP-1 receptor agonist originally licensed for type 2 diabetes management in the UK. Whilst semaglutide demonstrates proven efficacy for weight loss, its mechanism differs fundamentally from tirzepatide's dual-pathway approach [2]. Both medications slow gastric emptying and reduce appetite, but tirzepatide's additional GIP activity appears to amplify metabolic effects.

In head-to-head comparisons, the SURPASS-2 trial demonstrated that tirzepatide produced superior weight loss compared to semaglutide 1mg, with patients achieving average reductions of up to 15.7kg versus 5.7kg respectively over 40 weeks [1]. These findings suggest meaningful clinical differences between the two mechanisms, though individual responses vary based on metabolic factors and adherence.

Mounjaro vs Ozempic Effectiveness: Clinical Trial Data

The SURPASS-3 trial evaluated tirzepatide's efficacy in adults with obesity, demonstrating average body weight reductions of 22.5% at the 15mg maintenance dose over 72 weeks [1]. Participants lost an average of 25.3kg, with 63% achieving at least 20% total body weight reduction. These outcomes represent some of the most substantial weight loss results observed in pharmaceutical trials to date.

Semaglutide's efficacy was established through the STEP clinical trial programme, where participants receiving 2.4mg weekly injections achieved average weight loss of 14.9% over 68 weeks [2]. Whilst these results are clinically significant, they fall short of tirzepatide's outcomes in similar patient populations. The STEP 1 trial showed that 50.5% of semaglutide patients achieved at least 15% body weight reduction.

Direct comparison data from SURPASS-2 provides the clearest evidence of relative effectiveness. At comparable timepoints, tirzepatide 15mg produced nearly three times the weight reduction of semaglutide 1mg [3]. However, it's important to note that this trial used the 1mg diabetes dose of semaglutide rather than the 2.4mg dose used in dedicated weight loss formulations like Wegovy, which may narrow the efficacy gap.

Factors Affecting Individual Response

Clinical trial averages don't predict individual outcomes, as response to GLP-1 therapies varies significantly between patients. Your UK prescriber will consider your medical history, current medications, weight loss goals, and any contraindications when recommending between Mounjaro and Ozempic. Factors such as baseline BMI, insulin resistance severity, and adherence to lifestyle modifications all influence treatment success.

Some patients may experience better tolerability with one medication over the other, affecting long-term adherence. The gastrointestinal side effect profiles differ slightly between tirzepatide and semaglutide, with individual sensitivity playing a role in which medication proves more sustainable for continued use.

Dosing Schedules and Administration

Both Mounjaro and Ozempic are administered as once-weekly subcutaneous injections using pre-filled pens, making them equally convenient from a dosing frequency perspective. However, their titration schedules differ substantially. Mounjaro starts at 2.5mg weekly for four weeks, then increases to 5mg, with potential escalation to 7.5mg, 10mg, 12.5mg, or 15mg based on tolerability and response [4].

Ozempic follows a different escalation pattern, beginning at 0.25mg weekly for four weeks, increasing to 0.5mg, then potentially to 1mg or 2mg for diabetes management. For weight loss purposes, semaglutide formulations like Wegovy use a distinct titration schedule reaching 2.4mg weekly. The gradual dose increases for both medications help minimise gastrointestinal side effects during treatment initiation.

Injection technique is identical for both medications: patients inject into the abdomen, thigh, or upper arm, rotating sites weekly to prevent lipodystrophy. The KwikPen devices used for Mounjaro and Ozempic's injection pens are designed for ease of use, with clear dose windows and simple push-button administration suitable for self-injection at home.

Feature Mounjaro (Tirzepatide) Ozempic (Semaglutide)
Mechanism Dual GIP/GLP-1 receptor agonist Single GLP-1 receptor agonist
Average Weight Loss Up to 22.5% over 72 weeks Up to 14.9% over 68 weeks
Starting Dose 2.5mg weekly 0.25mg weekly
Maintenance Doses 5mg, 7.5mg, 10mg, 12.5mg, 15mg 0.5mg, 1mg, 2mg
Injection Frequency Once weekly Once weekly
Primary UK Licence Weight management & type 2 diabetes Type 2 diabetes
Nausea Incidence ~29% in trials ~20% in trials
Price at Cured Pharmacy From £69.00 Alternative: Wegovy from £89

Side Effects: Mounjaro vs Ozempic Comparison

Gastrointestinal side effects are the most common adverse events for both medications, though their frequency and severity differ slightly between tirzepatide and semaglutide. In clinical trials, nausea occurred in approximately 29% of Mounjaro patients versus 20% of Ozempic patients, whilst diarrhoea affected 19% and 9% respectively [1][2]. These effects typically diminish after the first few weeks as the body adjusts to treatment.

Vomiting, constipation, and abdominal discomfort represent additional gastrointestinal effects shared by both medications. The higher incidence with Mounjaro may relate to its dual receptor mechanism, though most patients find these effects manageable with dietary modifications and gradual dose titration. Eating smaller, more frequent meals and avoiding high-fat foods can significantly reduce symptom severity.

Serious adverse events remain rare for both medications but require awareness. Potential risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours observed in rodent studies (though not confirmed in humans) [4][5]. Both medications carry black box warnings regarding thyroid tumours and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Managing Side Effects During Treatment

Your UK prescriber will provide specific guidance on managing side effects, including when to contact medical professionals. Most gastrointestinal symptoms resolve within 4-6 weeks as your body adapts to the medication. Staying well-hydrated, eating slowly, and avoiding trigger foods helps minimise discomfort during the adjustment period.

If side effects prove intolerable at a particular dose, your prescriber may recommend maintaining your current dose longer before escalating, or in some cases, stepping back to a previous dose temporarily. Treatment decisions should always be made in consultation with your healthcare provider rather than adjusting doses independently.

Cost Considerations: Mounjaro vs Ozempic UK Pricing

Mounjaro pricing at Cured Pharmacy starts from £124.99 per month, with transparent costs displayed before your clinical consultation. This upfront pricing approach eliminates uncertainty, allowing you to make informed decisions about your weight loss treatment. All prices include the medication, UK prescriber assessment, and discreet delivery to your address.

Ozempic is primarily licensed for type 2 diabetes in the UK, though some prescribers may consider it off-label for weight management in appropriate patients. For dedicated weight loss treatment, Wegovy (semaglutide 2.4mg) represents the licensed alternative, available through Cured Pharmacy with the same transparent pricing model and clinical assessment process.

When comparing costs, consider the complete treatment journey rather than single-month pricing. Weight loss medications typically require several months of consistent use to achieve meaningful results, with clinical trials demonstrating peak efficacy between 40-72 weeks [1][2]. Your UK prescriber will discuss realistic timelines and expected investment during your consultation, ensuring you understand the commitment involved.

Which Treatment Is Right for You?

Choosing between Mounjaro and Ozempic depends on multiple factors including your weight loss goals, medical history, budget, and tolerance for potential side effects. Patients seeking maximum weight reduction based on current clinical evidence may prefer Mounjaro's dual-receptor mechanism, whilst those with cost sensitivity or previous positive experience with GLP-1 medications might opt for semaglutide-based alternatives.

Your eligibility for either medication requires assessment by a UK-registered prescriber, who will evaluate your BMI, existing health conditions, current medications, and contraindications. Both treatments are typically prescribed for adults with BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities such as hypertension or type 2 diabetes. NICE guidance and MHRA licensing determine prescribing parameters that UK clinicians must follow.

At Cured Pharmacy, our clinical team provides personalised recommendations based on your individual circumstances. The free online consultation takes under three minutes and connects you with UK prescribers who specialise in weight management. Whether Mounjaro, Wegovy, or alternative treatments prove most suitable, you'll receive expert guidance tailored to your specific needs and medical profile.

Getting Started with Treatment

Beginning treatment requires completing a clinical questionnaire covering your medical history, current medications, allergies, and weight loss objectives. UK prescribers review your responses to determine safety and suitability for GLP-1 therapy. If approved, your medication is dispensed from our UK-registered pharmacy and delivered discreetly to your chosen address, typically within 1-3 working days.

Ongoing support throughout your treatment journey includes access to our pharmacy team for questions about administration, side effects, or dose adjustments. Regular follow-up assessments ensure your treatment remains safe and effective, with prescribers monitoring your progress and making modifications as needed to optimise outcomes.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
  4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. https://www.gov.uk/ [accessed 13 August 2026]
  5. Medicines and Healthcare products Regulatory Agency. (2023). Ozempic 0.25 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. https://www.gov.uk/ [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What is the main difference between Mounjaro and Ozempic?
Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, whilst Ozempic (semaglutide) activates only GLP-1 receptors. This dual mechanism in Mounjaro has produced greater average weight loss in clinical trials—up to 22.5% versus 14.9% with semaglutide formulations.
Is Mounjaro more effective than Ozempic for weight loss?
Clinical trial data suggests Mounjaro produces greater average weight reduction than Ozempic, with SURPASS-2 showing tirzepatide achieved nearly three times the weight loss of semaglutide 1mg at comparable timepoints. Individual results vary based on metabolic factors and adherence.
Can I switch from Ozempic to Mounjaro?
Switching between medications is possible under prescriber supervision. Your UK clinician will assess your response to current treatment, side effect profile, and weight loss goals before recommending a switch. A transition plan including appropriate dose titration will be provided if approved.
Which has worse side effects: Mounjaro or Ozempic?
Both medications share similar gastrointestinal side effects, though Mounjaro shows slightly higher incidence rates in trials—nausea affected 29% versus 20% with Ozempic. Most side effects diminish within 4-6 weeks and can be managed with dietary modifications.
How much does Mounjaro cost compared to Ozempic in the UK?
Mounjaro starts from £124.99 at Cured Pharmacy. For licensed weight loss treatment with semaglutide, Wegovy represents the appropriate comparison rather than Ozempic, which is primarily licensed for diabetes. Your prescriber will discuss cost-effective options during consultation.
Do I need a prescription for Mounjaro or Ozempic in the UK?
Yes, both medications are prescription-only medicines in the UK and require clinical assessment by a UK-registered prescriber. Cured Pharmacy provides free online consultations where prescribers evaluate your suitability before dispensing either treatment.
How long does it take to see results with Mounjaro vs Ozempic?
Initial weight loss typically begins within 4-8 weeks of starting either medication, with progressive reductions over subsequent months. Peak efficacy occurs around 40-72 weeks based on clinical trials. Consistency with dosing and lifestyle modifications significantly influences results.
Can I use Mounjaro or Ozempic if I don't have diabetes?
Mounjaro is licensed in the UK for weight management in adults without diabetes who meet BMI criteria. Ozempic is primarily licensed for type 2 diabetes, though Wegovy (the same active ingredient at higher doses) is specifically licensed for weight loss. Your prescriber will recommend the appropriate medication for your situation.
What are the main differences between Mounjaro and Ozempic in the UK?
Mounjaro contains tirzepatide and targets both GIP and GLP-1 receptors, while Ozempic contains semaglutide and targets only GLP-1 receptors. Clinical trials show Mounjaro typically produces greater average weight loss, and Cured Pharmacy offers both medications with full prescriber support to help you choose the right option.
Is Mounjaro more expensive than Ozempic in the UK?
Mounjaro starts at £124.99 at Cured Pharmacy, while Ozempic pricing varies by dose and availability. Both medications require a prescription, and Cured Pharmacy offers competitive pricing on both with discount codes available for first orders.
Can I switch from Ozempic to Mounjaro through Cured Pharmacy?
Yes, you can switch from Ozempic to Mounjaro after a prescriber consultation at Cured Pharmacy. Our UK-registered prescribers will review your medical history and current treatment to ensure a safe transition, typically starting you on the appropriate Mounjaro dose based on your Ozempic experience.
Which is better for weight loss - Mounjaro or Ozempic?
Clinical studies show Mounjaro users achieved an average of 15-22% body weight loss compared to 10-15% with Ozempic, though individual results vary. Cured Pharmacy's prescribers can assess your specific health profile and weight loss goals to recommend whether Mounjaro or Ozempic is more suitable for you.
Does the NHS cover Mounjaro or Ozempic for weight loss in the UK?
NHS coverage for weight loss medications is extremely limited and typically restricted to specialist clinics with strict eligibility criteria. Cured Pharmacy offers private prescriptions for both Mounjaro and Ozempic with transparent pricing from £124.99, providing faster access with convenient home delivery across the UK.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.